APX-115

· Aptabio Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for APX-115, covering 2021-08-25 to 2026-06-10. Get the full timeline:

Most recent: Clinical Trial Results: A Phase 2 Study of APX-115 in Hospitalized Patients With Confirmed Mild to Moderate COVID-19. [Phase 2]